Showing 8391-8400 of 8647 results for "".
- Zeiss Introduces Integrated Diagnostic Imaging (IDI) Platform at ESCRShttps://modernod.com/news/zeiss-presents-integrated-data-driven-digital-solutions-at-escrs/2479859/Zeiss presented its newest digital diagnostic solutions for retinal diseases and glaucoma, along with new astigmatism management options in cataract surgery, this week at the ESCRS & EURETINA exhibition. “Digitalization o
- Bascom Palmer Treats First US Patient in Nightstar Gene Therapy Clinical Trial for X-Linked Retinitis Pigmentosahttps://modernod.com/news/bascom-palmer-treats-first-us-patient-in-nightstar-gene-therapy-clinical-trial-for-x-linked-retinitis-pigmentosa/2479869/A patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. On August 23, Julio Adorno Nieves, 23, of Puerto Rico, became the first U.S. patient to
- Positive PEACHTREE Data to be Highlighted at Euretina 2018https://modernod.com/news/positive-peachtree-data-to-be-highlighted-at-euretina-2018/2479871/Clearside Biomedical announced that data from PEACHTREE, its pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be presented by Ron Neumann, MD, Uveitis Specialist at Maccabi Health Services, Tel Aviv, Israel and co-Chair of
- FDA Grants Lin BioScience Rare Pediatric Disease Status for LBS-008 to Treat Stargardt Diseasehttps://modernod.com/news/fda-grants-lin-bioscience-rare-pediatric-disease-status-for-lbs-008-to-treat-stargardt-disease/2479877/Lin BioScience announced that the FDA has granted rare pediatric disease (RPD) designation to LBS-008, a first-in-class oral therapy for the treatment of Stargardt Disease. The Priority Review Voucher Program is intended to encourage development of therapies to prevent and treat rare pedi
- Oxurion to Present Scientific Findings Supporting Therapeutic Potential of THR-317 and THR-687 at EURETINAhttps://modernod.com/news/oxurion-to-present-scientific-findings-supporting-therapeutic-potential-of-thr-317-and-thr-687-at-euretina/2479880/Oxurion announced that it will give two presentations at the Euretina International Congress, which is being held in Vienna, Austria, from September 20-23, 2018. The presentation “Anti-inflammatory effects of the PlGF neutralizing antibody THR-317 in patients with diabetic macular edema” w
- Chinese Regulators Clear Takeda’s $62-Billion Takeover of Shirehttps://modernod.com/news/chinese-regulators-clear-takedas-62-billion-takeover-of-shire/2479882/Takeda said that China’s State Administration for Market Regulation has granted unconditional approval of its proposed $62-billion purchase of Shire. The Japanese drugmaker expects to complete the transaction in the first half of next year. China’s regulatory clearance “
- Diopsys Highlights Educational Initiatives For ESCRS 2018https://modernod.com/news/diopsys-highlights-educational-initiatives-for-escrs-2018/2479883/Diopsys announced educational initiatives for the ESCRS 2018 Congress in Vienna, Austria, September 22-26. In addition to presentations that highlight how the various forms of testing available on Diopsys devices add to the management of eye care patients, the company will also be introducing the
- LumiThera to Debut Valeda Light Delivery System at EURETINAhttps://modernod.com/news/lumithera-to-debut-valeda-light-delivery-system-at-euretina/2479887/LumiThera announced that it will debut the Valeda Light Delivery System for the treatment of dry AMD in the exhibition hall at the EURETINA meeting in Vienna. It will also host a symposium on photobiomodulation (PBM) technology entitled, “Photobiomodulation: An Innovative, Mitochondria-targ
- SightMD, 24-Location Ophthalmology Group, and Chicago Pacific Founders Set Partnershiphttps://modernod.com/news/sightmd-24-location-ophthalmology-group-and-chicago-pacific-founders-set-partnership/2479899/SightMD, a provider of eyecare services through 24 locations, and Chicago Pacific Founders Fund LP, a health care investment fund, announced that they are entering into a partnership to expand SightMD’s patient-centric care model to patients, providers, and payers across the New York, New Jersey
- New Joystick for the Keratograph 5M With Release Functionhttps://modernod.com/news/new-joystick-for-the-keratograph-5m-with-release-function/2479900/The Oculus Keratograph 5M now comes equipped with a new joystick, which includes a release function. The new feature enables the user to capture images and video sequences with the push of a button on the device. No need any more to switch to the mouse – the user’s hand stays resting on the new